Eli Lilly & Co. (LLY)

114.65
1.25 1.10
NYSE : Health Technology
Prev Close 113.40
Open 113.65
Day Low/High 113.22 / 114.83
52 Wk Low/High 84.64 / 132.13
Volume 2.81M
Avg Volume 6.08M
Exchange NYSE
Shares Outstanding 970.83M
Market Cap 108.48B
EPS 3.10
P/E Ratio 42.98
Div & Yield 2.58 (2.16%)
Jim Cramer: Many Reasons Why a Stock Market You Think Should Go Down, Doesn't

Jim Cramer: Many Reasons Why a Stock Market You Think Should Go Down, Doesn't

You should be thinking positively these days if your stock has had a run or even if it hasn't as a preponderance of good things is liable to happen.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

All three major averages closed Thursday's session in positive territory.

Feels Like the Semis Are Skating on Thin Ice: Market Recon

Feels Like the Semis Are Skating on Thin Ice: Market Recon

Forward looking valuations, except for Nvidia, are very low.

Here's My Take on Biotech Stocks

Here's My Take on Biotech Stocks

I think M&A activity will pick up markedly going forward across the industry.

Women's History Month: Nancy Lieberman -- Still Law Firm's Youngest Partner Ever

Women's History Month: Nancy Lieberman -- Still Law Firm's Youngest Partner Ever

For Women's History Month, Alpha Rising sat down with Nancy Lieberman, Of Counsel at Skadden, Arps. She was and still is the youngest person to ever make partner at her firm. She has worked on some of the biggest M&A deals in history -- and we should mention -- she's in a wheelchair and barely as use of her hands. Feel like a slacker yet? Good. Watch.

Eli Lilly: Is the Coast Now Clear for the Bulls?

Eli Lilly: Is the Coast Now Clear for the Bulls?

Traders should stay alert and nimble with LLY stock.

Eli Lilly Needs to Prove It Can Overcome Resistance Above $82

Eli Lilly Needs to Prove It Can Overcome Resistance Above $82

The price of LLY has climbed and the bearish price target on the Point and Figure chart is off the table.

Intermediate Trade: Eli Lilly

Intermediate Trade: Eli Lilly

Consider this LLY bullishly biased vertical call spread expiring in June.

Jim Cramer: Drug Stocks on the Move

Jim Cramer: Drug Stocks on the Move

We could be poised for even a further advance PROVIDED that we stay oversold.

Here's How Eli Lilly Stock Can Regain Its Footing

Here's How Eli Lilly Stock Can Regain Its Footing

Watch these key price levels on LLY.

Intermediate Trade: Eli Lilly

Intermediate Trade: Eli Lilly

Consider this LLY out of the money, bullishly biased vertical call spread expiring in April.

Jim Cramer: I Wish Some Stocks Would Not Keep Rallying

Jim Cramer: I Wish Some Stocks Would Not Keep Rallying

Facebook is making itself a tough own ahead of the quarterly results.

Big Pharma and the Sellers of Its Products Now Have a Problem

Big Pharma and the Sellers of Its Products Now Have a Problem

Who, out there in the health care sector, is safe?

A Rally in Eli Lilly Could Heal Traders, Investors

A Rally in Eli Lilly Could Heal Traders, Investors

Prices have improved the past eight weeks and now I want to turn up the volume.

Intermediate Trade: Eli Lilly

Intermediate Trade: Eli Lilly

This is a bullish trade, but it's best to use limit orders.

Some Afternoon Observations

* Thus far, my expectation of an "inside day" has been accurate. SPDR S&P 500 ETF  has traded in a fifty cent range most of the day. * Bonds are at the day's highs. +$0.88. Yield on the 10-year U.S. note is down by 3.5 basis points to 2.32% (where y...

Notable Movements

In terms of sector price movement today: * FANGs continue to extend recent gains.  * Retail has picked up a bid late in the day. Walmart Dillard's and Foot Locker are upside features. * Big Pharma stronger -- led by Merck ,Bristol-Myers Squibb , Lil...

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

The Dow had a record high close.

Cramer: How We Got Into This Rotation

Cramer: How We Got Into This Rotation

Everything's set up to compound it, and that's just what's happening.

Eli Lilly Had a Good Quarter but Investors Don't Want Health Stocks: Jim Cramer

Eli Lilly Had a Good Quarter but Investors Don't Want Health Stocks: Jim Cramer

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer said Eli Lilly LLY had a good quarter but the stock is getting hit by a rotation, as opposed to its specific performance.

Caterpillar, McDonald's and 3M Earnings Fuel Stock Rebound

Caterpillar, McDonald's and 3M Earnings Fuel Stock Rebound

Strong earnings from Dow components Caterpillar, McDonald's and 3M were on track to push the blue-chip index higher after a 0.23% decline on Monday.

Eli LIlly Beats, Sears Cuts Whirlpool: Tuesday's Top Stories

Eli LIlly Beats, Sears Cuts Whirlpool: Tuesday's Top Stories

Top stories today: Eli Lilly is raising its projections for the entire year since its newer drugs are doing well, Sears stops selling Whirlpool appliances in their stores and President Trump meets with lawmakers to discuss tax reform.

How to Manage GE Risk and the Netflix-Disney Fight: Market Recon

How to Manage GE Risk and the Netflix-Disney Fight: Market Recon

Entering GE too early has its costs, but there are ways to mitigate them.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

The Dow closed at a new record Tuesday.

Lilly Is Testing Old Resistance

Lilly Is Testing Old Resistance

Stock is neither bullish nor bearish right now.